We have now focused on understanding the regulators and targets of non-canonical NFκB activation in podocytes in response to TWEAK, a cytokine that promotes glomerular injury in experimental animals and is currently the target of clinical trials in human glomerular disease. The gene discussed is TNFSF12; the disease is glomerular disorder.